Search results for "subtotal parathyroidectomy"

showing 4 items of 4 documents

Intraoperative Parathyroid Hormone Monitoring During Parathyroidectomy for Hyperparathyroidism in Waiting List and Kidney Transplant Patients

2006

This report describes the use of the intraoperative parathyroid hormone (ioPTH) assay during parathyroidectomy in waiting list and transplanted patients. ioPTH levels were determined in 40 patients on the waiting list for kidney transplantation with secondary hyperparathyroidism who underwent subtotal parathyroidectomy and 9 transplanted patients with tertiary hyperparathyroidism who underwent removal of hyperplasic glands. Rapid PTH levels decreased significantly at each time period; the percentage decrease in rapid PTH levels was 61.3% among patients with IPT II and 70.2% in patients with IPT III at 10 minutes and 86.5% in patients with IPT II and 91% in patients with IPT III at 15 minute…

AdultMaleParathyroidectomymedicine.medical_specialtyWaiting Listsmedicine.medical_treatmentParathyroid hormoneTertiary hyperparathyroidismKidney transplantSubtotal ParathyroidectomyParathyroid GlandsMonitoring IntraoperativePreoperative Careparasitic diseasesmedicineHumansPostoperative PeriodKidney transplantationParathyroidectomyTransplantationHyperparathyroidismbusiness.industryHyperparathyroidismMiddle Agedmedicine.diseaseKidney TransplantationSurgeryAdult Female Humans Hyperparathyroidism/classification Hyperparathyroidism/etiology Hyperparathyroidism/surgery* Kidney Failure Chronic/complications* Kidney Transplantation* Male Middle Aged Monitoring Intraoperative/methods* Parathyroid Glands/surgery Parathyroid Hormone/blood* Parathyroidectomy* Postoperative Period Preoperative Care Waiting ListsParathyroid HormoneKidney Failure ChronicFemaleSurgerySecondary hyperparathyroidismbusinessTransplantation Proceedings
researchProduct

Use of monitoring intraoperative parathyroid hormone during parathyroidectomy in patients on waiting list for renal transplantation.

2007

This report describes the use of intraoperative parathyroid hormone (ioPTH) assay during parathyroidectomy for patients with secondary hyperparathyroidism on the waiting list for renal transplantation. The levels of ioPTH were determined among waiting list patients undergoing subtotal parathyroidectomy and tertiary hyperparathyroidism patients undergoing procedures. The levels of ioPTH were significantly reduced at 10 minutes by 59.7,3% among with secondary hyperparathyroidism and 68.9% among tertiary hyperparathyroidism. A 15 minutes it was 85% in secondary hyperparathyroidism and 89.7% in tertiary hyperparathyroidism. A decrement of 50% in basal values at 10 minutes and 85% decrement or m…

ParathyroidectomyAdultMalemedicine.medical_specialtyendocrine system diseasesWaiting Listsmedicine.medical_treatmentParathyroid hormoneTertiary hyperparathyroidismSubtotal ParathyroidectomyMonitoring IntraoperativemedicineHumansKidney transplantationAgedParathyroidectomyTransplantationbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureParathyroid HormoneSurgerySecondary hyperparathyroidismParathyroid glandFemaleHyperparathyroidism SecondarybusinessParathyroidectomy hyperparathyroidismTransplantation proceedings
researchProduct

Reoperation for persistent or recurrent secondary hyperparathyroidism. Surgical treatment of renal hyperparathyroidism

2017

Background: Secondary hyperparathyroidism is a common acquired disorder seen in chronic renal failure. Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. When medical treatment fails, subtotal and total parathyroidectomy with autotransplantation are the standard procedures, although both are associated with high recurrence rates. Methods and Results: 4 patients experienced persistence and 9 relapse. The first 4 were subjected to reoperation after 6 months for the persistence of symptoms due to the finding of a supernumerary adenomatous gland while the remaining patients at the reoperation showed in 5 cases 2 more glands in over thymic position, a…

ParathyroidectomyReoperationrecurrent hyperparathyroidismRecurrenceRenal Dialysispersistent hyperparathyroidismsubtotal parathyroidectomyHumansKidney Failure ChronicCase ReportHyperparathyroidism Secondaryintraoperative parathyroid hormone measurementRetrospective StudiesActa bio-medica : Atenei Parmensis
researchProduct

Reoperation for persistent or recurrent secondary hyperparathyroidism

2017

Background: Secondary hyperparathyroidism is a common acquired disorder seen in chronic renal failure. Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. When medical treatment fails, subtotal and total parathyroidectomy with autotransplantation are the standard procedures, although both are associated with high recurrence rates.Methods and Results: 4 patients experienced persistence and 9 relapse. The first 4 were subjected to reoperation after 6 months for the persistence of symptoms due to the finding of a supernumerary adenomatous gland while the remaining patients at the reoperation showed in 5 cases 2 more glands in over thymic position, an…

Settore MED/18 - Chirurgia Generaleintraoperative parathyroid hormone measurement; persistent hyperparathyroidism; recurrent hyperparathyroidism; subtotal parathyroidectomyrecurrent hyperparathyroidismpersistent hyperparathyroidismsubtotal parathyroidectomyIntraoperative parathyroid hormone measurementSettore MED/13 - Endocrinologia
researchProduct